Toxicological Aspects of Synthetic Drugs Barry K. Logan, PhD, DABFT Synthetic Drugs[removed]

First Page		Document Content
Date: 2013-04-29 11:59:29 Aminoalkylindoles JWH-210 JWH-018 RCS-8 JWH-073 JWH-203 JWH-019 JWH-250 JWH-200 Cannabis Cannabinoids Synthetic Cannabis		Toxicological Aspects of Synthetic Drugs Barry K. Logan, PhD, DABFT Synthetic Drugs[removed] Add to Reading List Source URL: www.nist.gov Download Document from Source Website File Size: 1,32 MB Share Document on Facebook

	Metabolites account for most of the observed therapeutic effect of the cannabinoids. However, to date, limited research has been conducted in order to identify metabolites and to understand their biological activity and DocID: 1v7wB - View Document
	April 25, 2018 Contaminated Street Drug Supply Synthetic Cannabinoids and Kratom The Ontario Poison Centre (OPC) has been made aware of two separate issues potentially affecting the DocID: 1uHtb - View Document
	Health Advisory: Significant Bleeding Associated with Contaminated Synthetic Cannabinoids DocID: 1uwJY - View Document
	New Test Announcement Expanded Qualitative Synthetic Cannabinoids (K2, SPICE) Test # DocID: 1uriU - View Document
	Synthetic Cannabinoids “Spice” Drugs Confirmations LC-MS/MS and GC-MS using CLEAN SCREEN® THC SPE Column CSTHC206 April 7, PREPARE SAMPLE DocID: 1uqgf - View Document